Abnormal zinc and copper metabolism in hepatic steatosis.
Abnormal Zinc and Copper metabolism were studied in rats with tetracycline-induced fatty liver and compared with normal rats. The present work recorded decreased serum zinc concentration with increased copper concentration in the tetracycline-injected rats. The results also showed that the liver and heart zinc were significantly decreased; meanwhile it was observed that the concentration of zinc in the kidney tissue of fatty liver rats was significantly raised in comparison with those of normal rats. Histopathological studies of the kidney tissue showed degenerative changes in the tables with areas of focal necrosis. Renal tubular necrosis in such cases is largely caused by the toxic degradation products of tetracycline metabolism. The kidney lesion together with impaired gastrointestinal absorption contributed to the hypozincaemia observed in the present results. Although the present data showed a significant reduction in serum zinc and significant rise in plasma insulin in the fatty liver rats there was nonsignificant correlation between the two variables as compared with the normal rats. The positive correlation between serum zinc concentration and reduced high-density lipoprotein cholesterol (HDL-C) emphasizes the role of zinc deficiency in atherosclerotic disease in fatty liver.
Mikhail
T H
TH
Physiology unit, National Research Centre.
Nicola
W G
WG
Ibrahim
K H
KH
Salama
S H
SH
Emam
M
M
D000818:Animals; D003300:Copper / Q000378:metabolism*; D005234:Fatty Liver / Q000139:chemically induced / Q000378:metabolism* / Q000503:physiopathology; D005260:Female; D006946:Hyperinsulinism / Q000097:blood / Q000503:physiopathology; D008074:Lipoproteins / Q000097:blood; D008297:Male; D051381:Rats; D013754:Tetracyclines; D015032:Zinc / Q000378:metabolism*
D008074:Lipoproteins; D013754:Tetracyclines; D003300:Copper; D015032:Zinc